Expert US stock credit rating analysis and default risk assessment to identify financial distress signals. We monitor credit markets to understand the health of companies and potential risks to equity holders.
As of 2026-04-13, The Beauty Health Company (SKIN) trades at a current price of $0.88, marking a 1.54% decline from the previous session’s close. This analysis evaluates key technical levels, recent sector context, and potential short-term price scenarios for SKIN, with no company-specific material news driving price action in recent sessions. No recent earnings data is available for the company at the time of writing, so near-term price movements are primarily tied to technical trading patterns
Is The Beauty (SKIN) Stock in a Selling Zone | Price at $0.88, Down 1.54% - Analyst Upgrade
SKIN - Stock Analysis
3205 Comments
1485 Likes
1
Maketa
Community Member
2 hours ago
US stock competitive benchmarking and market share trend analysis for understanding relative company performance and competitive positioning. Our competitive analysis helps you identify which companies are winning or losing market share in their respective industries over time. We provide market share analysis, competitive benchmarking, and share trend tracking for comprehensive coverage. Understand competitive position with our comprehensive benchmarking and market share analysis tools for strategic investing.
👍 187
Reply
2
Wealth
Trusted Reader
5 hours ago
Who else is here because of this?
👍 274
Reply
3
Aoki
New Visitor
1 day ago
That made me spit out my drink… in a good way. 🥤💥
👍 239
Reply
4
Kayann
Power User
1 day ago
Market fluctuations continue to test investor patience, emphasizing the need for proper risk management.
👍 140
Reply
5
Kaisen
Expert Member
2 days ago
I always seem to find these things too late.
👍 61
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.